Search

everythinglearnresearchcommunity

for

Search:↓

A woman's excessive hair growth and masculine features were due to a rare benign ovarian tumor and endometrial cancer, which improved after surgery.

A 63-year-old woman's male-like symptoms were caused by a rare testosterone-producing ovarian tumor, treated by removing her ovaries and fallopian tubes.

A postmenopausal woman's virilization was caused by a rare ovarian tumor that was hard to detect but was successfully treated with surgery.

Woman with diabetes had hair loss due to rare ovarian tumor; surgery improved hair growth.

Triptorelin helps evaluate hormone production in Sertoli-Leydig cell tumors.

Surgery on a 68-year-old woman with an ovarian tumor led to reduced hirsutism and normal testosterone levels.

Leydig cell tumors can cause high testosterone and symptoms in postmenopausal women, and removing them improves symptoms.

A woman's severe male hormone excess was caused by a small, hard-to-find ovarian tumor.

Some ovarian tumors can cause masculinization, and it's important to check for various causes when this symptom is present.

Ovarian vein sampling helped diagnose rare ovarian tumors causing high testosterone, and surgery to remove the tumors lowered the testosterone levels.

The removed ovarian tumor was a rare type of blood vessel tumor that improved the patient's symptoms and hormone levels after surgery.

Combining flutamide and finasteride can reduce prostate weight and tumor growth, potentially benefiting treatments needing optimal DHT inhibition.

A postmenopausal woman's masculine symptoms improved after surgery for a hormone-producing ovarian tumor.

Doctors used a special blood sampling technique to diagnose a woman's rare ovarian tumor that was producing male hormones.

GnRH analogues are effective for diagnosing and treating female androgen excess, offering a non-surgical option.

Removing a testosterone-producing tumor cured a woman's sleep apnea and other symptoms.

The conclusion is that thorough investigation of hypertension and hormonal dysfunctions is important, and there may be a link between these conditions and cancer.

Treatment with a hormone agonist can reduce excess male hormones in postmenopausal women without surgery.

Sertoliform endometrioid carcinoma of the ovary, though rare, has a good prognosis when treated early.

The conclusion is that oral contraceptives and antiandrogens can treat hirsutism and acne in women with cutaneous hyperandrogenism, but more research is needed for effective treatments, especially for hair loss.

The patient's high testosterone was reduced by a medication that suppresses gonadotropin.

The document concludes that accurate diagnosis of male and female gonadal disorders is crucial for effective treatment and better patient outcomes.

A special blood test helped find the overactive ovary in a teen with PCOS, and removing that ovary improved her condition.

Compounds 4, 4b, and 4c effectively inhibit an enzyme linked to testosterone conversion without significant toxicity.

Steroid sulfatase is important for activating hormones that affect memory, brain function, and certain diseases, and could be a target for treating hormone-related disorders.

The document concludes that treating female hair loss should target reducing excess androgen and blocking its effects on hair follicles, with the best treatments being hormonal therapy, adrenal suppression, and topical minoxidil.

The report concludes that PCOS is mainly a condition of excess male hormones and its definition may change as new information is discovered.

Certain gene patterns in breast cancer are linked to how active hormone receptors are and could affect patient survival.

A woman's adrenal tumor disappeared after treatment with cyproterone acetate.

Progranulin overexpression leads to shorter, thinner hair and increased cell death in mouse hair follicles.